Physician profile
Melissa E Fraley
NPI 1164455127
$810.38
in general payments reported to CMS, 2019-2025
10 companies · $177 in 2025
The $177 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $182 · 2022: $195 · 2023: $120 · 2024: $136 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $433.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $433.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $337.47 | 2021-2022 | |
| Abbott Laboratories | $132.18 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Zimmer Biomet Holdings, INC. | $124.98 | 2025 | Venapax |
| Stryker Corporation | $37.27 | 2023 | Spy-Phi System |
| Biomerieux INC | $37.05 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.03 | 2023 | Lifevest |
| Medtronic, INC. | $34.60 | 2025 | Penditure |
| Abiomed | $31.20 | 2024 | Impella |
| Kerecis Limited | $20.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Davol INC. | $17.62 | 2023 | Tridyne Vascular Sealant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Fraley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.